2019
Khanna, Rajesh, et al. “Development and Characterization of An Injury-Free Model of Functional Pain in Rats by Exposure to Red Light.”. J Pain, vol. 20, no. 11, Jan. 2019, pp. 1293-06, https://doi.org/10.1016/j.jpain.2019.04.008.
Wahl, JR, et al. “Migraine, A Review of Basic, Clinical, Translational Approaches to New Treatment”. ARCH Women Health Care, vol. 2, no. 6, Jan. 2019, pp. 1-5.
Chen, Zhoumou, et al. “Sphingosine-1-Phosphate Receptor 1 Activation in Astrocytes Contributes to Neuropathic Pain.”. Proc Natl Acad Sci U S A, vol. 116, no. 21, Jan. 2019, pp. 10557-62, https://doi.org/10.1073/pnas.1820466116.
Lei, Wei, et al. “The Alpha Isoform of Heat Shock Protein 90 and the Co-Chaperones P23 and Cdc37 Promote Opioid Anti-Nociception in the Brain.”. Front Mol Neurosci, vol. 12, Jan. 2019, p. 294, https://doi.org/10.3389/fnmol.2019.00294.
2018
Streicher, John M, and Bilsky, Edward J. “Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.”. J Pharm Pract, vol. 31, no. 6, Dec. 2018, pp. 658-69, https://doi.org/10.1177/0897190017732263.
Zhang, Hong, et al. “Peripherally Restricted Cannabinoid 1 Receptor Agonist As a Novel Analgesic in Cancer-Induced Bone Pain.”. Pain, vol. 159, no. 9, Sept. 2018, pp. 1814-23, https://doi.org/10.1097/j.pain.0000000000001278.
Edwards, Katie A, et al. “A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain.”. J Pain, vol. 19, no. 6, Jan. 2018, pp. 612-25, https://doi.org/10.1016/j.jpain.2018.01.002.
Abdullahi, Wazir, et al. “Blood-Brain Barrier Dysfunction in Ischemic Stroke: Targeting Tight Junctions and Transporters for Vascular Protection.”. Am J Physiol Cell Physiol, vol. 315, no. 3, Jan. 2018, pp. C343-C356, https://doi.org/10.1152/ajpcell.00095.2018.
Pandit, Viraj, et al. “Continuous Remote Ischemic Conditioning Attenuates Cognitive and Motor Deficits from Moderate Traumatic Brain Injury.”. J Trauma Acute Care Surg, vol. 85, no. 1, Jan. 2018, pp. 48-53, https://doi.org/10.1097/TA.0000000000001835.
Williams, Sigrid G, et al. “Effects of Legislation Regulating Abortion in Arizona.”. Womens Health Issues, vol. 28, no. 4, Jan. 2018, pp. 297-00, https://doi.org/10.1016/j.whi.2018.02.002.
Cottier, Karissa E, et al. “Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery.”. ENeuro, vol. 5, no. 4, Jan. 2018, https://doi.org/10.1523/ENEURO.0116-18.2018.
Olson, Keith M, et al. “Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer That Reduces Morphine Withdrawal in Mice.”. J Med Chem, vol. 61, no. 14, Jan. 2018, pp. 6075-86, https://doi.org/10.1021/acs.jmedchem.8b00403.
Shah, Nirav, et al. “TAK1 Activation of Alpha-TAT1 and Microtubule Hyperacetylation Control AKT Signaling and Cell Growth.”. Nat Commun, vol. 9, no. 1, Jan. 2018, p. 1696, https://doi.org/10.1038/s41467-018-04121-y.
2017
Keresztes, Attila, and Streicher, John M. “Synergistic Interaction of the Cannabinoid and Death Receptor Systems - a Potential Target for Future Cancer Therapies?”. FEBS Lett, vol. 591, no. 20, Oct. 2017, pp. 3235-51, https://doi.org/10.1002/1873-3468.12863.
Cartmell, Christopher, et al. “Synthetic Analogues of Cyanobacterial Alkaloid Cylindrospermopsin and Their Toxicological Activity.”. Toxicol In Vitro, vol. 44, Oct. 2017, pp. 172-81, https://doi.org/10.1016/j.tiv.2017.07.007.
Grenald, Shaness A, et al. “Targeting the S1P S1PR1 Axis Mitigates Cancer-Induced Bone Pain and Neuroinflammation.”. Pain, vol. 158, no. 9, Sept. 2017, pp. 1733-42, https://doi.org/10.1097/j.pain.0000000000000965.
Nelson, Michele A, et al. “Anti-NMDA Receptor Encephalitis Presenting As a Primary Psychotic Disorder”. Ann Clin Psychiatry, vol. 29, no. 3, Aug. 2017, pp. 205-6.
Abdullahi, Wazir, et al. “Bone Morphogenetic Protein-9 Increases the Functional Expression of Organic Anion Transporting Polypeptide 1a4 at the Blood-Brain Barrier via the Activin Receptor-Like Kinase-1 Receptor.”. J Cereb Blood Flow Metab, vol. 37, no. 7, July 2017, pp. 2340-5, https://doi.org/10.1177/0271678X17702916.
Abdullahi, Wazir, et al. “Functional Expression of P-Glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?”. AAPS J, vol. 19, no. 4, July 2017, pp. 931-9, https://doi.org/10.1208/s12248-017-0081-9.
Lochhead, Jeffrey J, et al. “Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System.”. AAPS J, vol. 19, no. 4, July 2017, pp. 910-2, https://doi.org/10.1208/s12248-017-0076-6.
Xie, Jennifer Y, et al. “Kappa Opioid Receptor Antagonists: A Possible New Class of Therapeutics for Migraine Prevention.”. Cephalalgia, vol. 37, no. 8, July 2017, pp. 780-94, https://doi.org/10.1177/0333102417702120.
Stefanucci, Azzurra, et al. “Fluorescent-Labeled Bioconjugates of the Opioid Peptides Biphalin and DPDPE Incorporating Fluorescein-Maleimide Linkers.”. Future Med Chem, vol. 9, no. 9, June 2017, pp. 859-6, https://doi.org/10.4155/fmc-2016-0232.
Grenald, Shaness A, et al. “Synergistic Attenuation of Chronic Pain Using Mu Opioid and Cannabinoid Receptor 2 Agonists.”. Neuropharmacology, vol. 116, Apr. 2017, pp. 59-70, https://doi.org/10.1016/j.neuropharm.2016.12.008.
Wheeler, Sarah E, and Lee, Nam Y. “Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy.”. J Cell Physiol, vol. 232, no. 3, Mar. 2017, pp. 486-9, https://doi.org/10.1002/jcp.25506.
Olson, Keith M, et al. “Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.”. Yale J Biol Med, vol. 90, no. 1, Mar. 2017, pp. 97-110.